During the past decade, Clinical Investigation Specialists, Inc conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 33 clinical trials were completed, i.e. on average, 113.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 17 clinical trials were completed. i.e. 154.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Investigation Specialists, Inc" #1 sponsor was "Pfizer" with 11 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Investigation Specialists, Inc" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Investigation Specialists, Inc" are "Migraine" (5 trials), "Overactive Bladder" (4 trials), "Cardiovascular Disease" (3 trials), "Hypertension" (3 trials) and "Obesity" (3 trials). Many other conditions were trialed in "Clinical Investigation Specialists, Inc" in a lesser frequency.

Most popular intervention types in "Clinical Investigation Specialists, Inc" are "Drug" (49 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Darusentan" (2 trials), "Diclofenac" (2 trials), "Empagliflozin" (2 trials) and "Rimegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Investigation Specialists, Inc" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Investigation Specialists, Inc". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Clinical Investigation Specialists, Inc, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Investigation Specialists, Inc, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".